Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

Lancet
Christian LaurentEric Delaporte

Abstract

Generic fixed-dose combinations have been prequalified by WHO to treat HIV-infected patients in resource-limited countries. Despite their widespread use they are, however, not yet recommended by some of the major donor agencies owing to scarcity of clinical data on effectiveness, safety, and quality. We aimed to assess these issues for one of the most frequently prescribed treatments in Africa, a generic fixed-dose combination of nevirapine, stavudine, and lamivudine. 60 patients were followed in an open-label, 24-week multicentre trial in Cameroon. All patients received one tablet of the fixed-dose combination drug twice daily. The primary outcome measure was the proportion of patients with viral load less than 400 copies per mL at the end of the study period, in an intention-to-treat analysis. At baseline, 92% of patients (n=55) had AIDS; median CD4 count was 118 cells per microL (IQR 78-167) and median plasma HIV-1 RNA was 104?736 copies per mL (40804-243787). The proportion of patients with undetectable viral load (<400 copies per mL) after 24 weeks of treatment was 80% (95% CI 68-89). Median (IQR) change in viral load was -3.1 log10 copies per mL (-2.5 to -3.6) and in CD4 count 83 cells per microL (40-178). The probability...Continue Reading

Citations

Dec 14, 2005·Current HIV/AIDS Reports·Catherine Orrell
Jul 3, 2007·Transactions of the Royal Society of Tropical Medicine and Hygiene·Elin C LarssonAnna Mia Ekström
Jul 21, 2009·Lancet·Mark BoydDavid A Cooper
Sep 15, 2006·The New England Journal of Medicine·Sue J GoldieKenneth A Freedberg
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thanyawee PuthanakitVirat Sirisanthana
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louise C IversKaren Doucette
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chitra AkileswaranKenneth H Mayer
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Charles B HolmesRochelle P Walensky
Aug 22, 2006·The Journal of Infectious Diseases·Robert W Shafer
Jan 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Somnuek SungkanuparphWasun Chantratita
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bijal ShahAmita Gupta
Jan 10, 2008·The Journal of Infectious Diseases·Lisa R HirschhornWilliam Rodriguez
Sep 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ramnath SubbaramanNagalingeswaran Kumarasamy
Nov 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Habib O RamadhaniJohn A Crump
Jan 2, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Melissa A BenderKenneth A Freedberg
Apr 22, 2008·AIDS Patient Care and STDs·N KumarasamyKenneth H Mayer
Mar 8, 2005·AIDS·Jean-Christophe PlantierFrançois Simon
Aug 2, 2008·AIDS·Joshua A Salomon, Daniel R Hogan
Jun 12, 2010·Current Opinion in HIV and AIDS·Sandrine LoubiereYazdan Yazdanpanah
Oct 30, 2012·Pharmacogenetics and Genomics·Julie BertrandUNKNOWN ANRS 12154 Study Group
Aug 6, 2011·The Pediatric Infectious Disease Journal·Joseph FokamGiulia Cappelli
Apr 26, 2007·AIDS·Rochelle P WalenskyUNKNOWN CEPAC International Investigators
Dec 20, 2007·AIDS·Laurent FerradiniJean-François Delfraissy
Jun 16, 2011·AIDS·Josep M LlibreUNKNOWN Spanish Group for FDAC Evaluation

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.